Skip to main content
Public beta This website is in public beta – please give your feedback.

Example clinical scenario

You are reviewing a 10-year-old boy in your clinic, who has been diagnosed with Crohn’s disease. His parents mention they are thinking about extending their family and would like to know if there is a risk of future children being affected.

When to consider genomic testing

  • Inflammatory bowel disease (IBD) is usually caused by complex interactions between genetic and environmental factors and typically presents during adolescence/early adulthood.
  • The presence of a family history of IBD alone does not meet eligibility criteria for genomic testing in the National Genomic Test Directory.
  • For a small number of patients with inflammatory bowel disease, often presenting in early childhood with additional features such as immunodeficiency, there may be a monogenic cause. In this context, genomic testing is available for affected children.

What do you need to do?

  • If there is a family history of IBD with no additional features to make you suspect a monogenic form, no genomic testing is indicated.
    • Instead, explain to the family that the presence of a family history of the IBD does slightly increase the risk of further family members being affected, but there is no testing that can usefully be done in this context.
  • If you suspect a monogenic form of IBD (for instance where there is onset in early childhood, additional features such as immunodeficiency and/or inflammation or autoimmunity, congenital defects, early malignancy), consult Presentation: Child with suspected monogenic inflammatory bowel disease for eligibility criteria for genomic testing of an affected individual.

Resources

For clinicians

References:

↑ Back to top
  • Last reviewed: 28/02/2025
  • Next review due: 28/02/2026
  • Authors: Dr Tom Butler, Dr Amy Frost
  • Reviewers: Dr Kevin Monahan, Dr Laura Kelly